<i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Cancer Research|2022Cited by 17
Hepatic zonation determines tumorigenic potential of mutant β-cateninAlexander Raven, Owen J. Sansom, Catriona A. Ford et al.|Nature|2025Cited by 5
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0